bp101
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Mar 14, 2016 (NCT03080298)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bp101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03463707 | Phase 3 | Mar 5, 2018 | IVIX Ltd. |
| NCT03102489 | Phase 1 | Feb 22, 2017 | IVIX Ltd. |
| NCT03080298 | Phase 2 | Mar 14, 2016 | IVIX Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| IVIX Ltd. | For profit | 3 | 3 | 3 | 2016 |
1 organizations
Page 1 / 1